Mental Health Service Utilization by Borderline Personality Disorder Patients and Axis II Comparison Subjects Followed Prospectively for 6 Years
The DOI matches its Crossref record.
Abstract
OBJECTIVE: The purpose of this study was to describe the psychiatric treatment received by a well-defined sample of patients with borderline personality disorder and Axis II comparison subjects over 6 years of prospective follow-up. METHOD: 362 inpatients were interviewed about their treatment histories during their index admission (1992-1995). 290 patients met both Revised Diagnostic Interview for Borderlines and DSM-III-R criteria for borderline personality disorder and 72 met DSM-III-R criteria for at least 1 nonborderline Axis II disorder (and neither criteria set for borderline personality disorder). Over 94% of surviving patients were re-interviewed about their psychiatric treatment histories 2, 4, and 6 years later. RESULTS: Only 33% of borderline patients were hospitalized during the final 2 years of the 6-year follow-up, a substantial decline from the 79% who had prior hospitalizations at baseline. Much the same pattern emerged for day and/or residential treatment (from 55% to 22%). In contrast, about three quarters of borderline patients were still in psychotherapy and taking psychotropic medications after 6 years of follow-up. Additionally, over 70% of borderline patients participating in these outpatient modalities did so for at least 75% of each follow-up period. While rates of intensive psychotherapy declined significantly over time (from 36% to 16%), rates of intensive polypharmacy remained relatively stable over time, with about 40% of borderline patients taking 3 or more concurrent standing medications during each follow-up period, about 20% taking 4 or more, and about 10% taking 5 or more. CONCLUSIONS: The results of this study suggest that the majority of borderline patients continue to use outpatient treatment in a sustained manner through 6 years of follow-up, but only a declining minority use more restrictive and costly forms of treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous studies on individuals with PD diagnoses demonstrated that BPD individuals differ in usage of outpatient, inpatient, and psychopharmacologic treatments when compared to other PD groups [7,8]”
Citations
Cited by
Items 201–284 of 284
The treatment of borderline personality disorder patients with current suicidal behaviour.
Barbe, R., Rubovszky, G., Venturini-Andreoli, A., & Andreoli, A. (2005) · Cited by 6
Pharmacotherapy of Borderline Personality Disorder
Webber, M. A., & Farrell, J. M. (2008) · Psychopharm Review · doi:10.1097/01.idt.0000338579.72194.97 · Cited by 5
“demonstrated that 40% of patients with BPD took three or more psychotropic medications, 20% took four or more, and 10% took five or more over a follow-up period of 6 years.(26) No evidence, however, supports this widespread contemporary practice.”
BackgroundChildhood predictors of antipsychotic use among young people in Finland
Gyllenberg, D., Sourander, A., Helenius, H. Y. M., Sillanmäki, L. H., Huttunen, J., Piha, J., Kumpulainen, K., Tamminen, T., Moilanen, I. K., & Almqvist, F. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3265 · Cited by 6
Borderline personality disorder: STEPPS improves symptoms
Davidson, K. M. (2008) · Evidence-Based Mental Health · doi:10.1136/ebmh.11.4.120 · Cited by 4
Levy, K. N., & Ellison, W. D. (2022) · Training and Education in Professional Psychology · doi:10.1037/tep0000376 · Cited by 7
“…that between 20–45% of psychiatric outpatients and 45-50% of inpatients meet criteria for a personality disorder (Korzekwa, Dell, Links, Thabane, & Webb, 2008; Kovanicova, Kubasovska, & Pallayova, 2020; Marinangeli et al., 2000; Zanarini et al., 2004; Zimmerman, Rothschild, & Chelminski, 2005).”
BackgroundKantojärvi, L., Hakko, H. H., Mukka, M., Käyhkö, A., Riipinen, P. K., & Riala, K. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113449 · Cited by 5
Antiepileptic Drugs and Borderline Personality Disorder
Zanarini, M. C. (2008) · Medical psychiatry · doi:10.3109/9780849382666.018 · Cited by 4
Self-citationLoya, J. M., Wagner, A., Pittman, B. P., & Davis, M. T. (2024) · Personality Disorders Theory Research and Treatment · doi:10.1037/per0000643 · Cited by 5
Niesten, I. J. M., Glass, I. V., & Zanarini, M. C. (2024) · Journal of Trauma & Dissociation · doi:10.1080/15299732.2024.2383192 · Cited by 3
“Indeed, we know from previous research among this sample that a substantial number of patients continued outpatient treatment as usual in the community over 6, 10, and 16-year follow-ups (Hörz et al., 2010; Zanarini et al., 2004, 2015).”
Self-citationCailhol, L., & Ragonnet, C. (2012) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/j.amp.2012.06.025 · Cited by 4
Borderline Personality Disorder and the Eating Disorders in the Perinatal Period
Blankley, G., Power, J., & Chanen, A. M. (2014) · Springer eBooks · doi:10.1007/978-3-642-54562-7_11 · Cited by 3
Cha, Y., Links, P. S., Ba, D., & Kazi, A. (2024) · American Journal of Men s Health · doi:10.1177/15579883241271894 · Cited by 4
“Individuals with BPD are significant users of health services (Zanarini et al., 2004) with a lifetime risk of suicide ranging between 3% and 10% (Paris & Zweig-Frank, 2001).”
BackgroundGoodman, M. S., Vail, L., West, S., New, A. S., & Siever, L. J. (2007) · International Journal of Systemic Therapy · doi:10.1300/j085v17n03_04 · Cited by 3
“Patients with personality disorders are high-level consumers of mental health resources (Bender et al., 2001; Zanarini et al., 2004).”
BackgroundGregory, R. J. (2005) · Evidence-Based Mental Health · doi:10.1136/ebmh.8.2.50 · Cited by 3
Brief Report: Borderline Personality Disorder and Mental Healthcare Service Use Among Adolescents
Cailhol, L., Jeannot, M., Rodgers, R. F., Guelfi, J., Pérez-Díaz, F., Pham‐Scottez, A., Corcos, M., & Speranza, M. (2012) · Journal of Personality Disorders · doi:10.1521/pedi_2012_26_041 · Cited by 3
Tyrer, P. J., Tyrer, H., & Yang, M. (2022) · Personality and Mental Health · doi:10.1002/pmh.1535 · Cited by 3
Managing treatment-resistant depression with comorbid personality disorders
Voytenko, V. L., & Huprich, S. K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824067-0.00030-x · Cited by 6
The Art of Prescribing. Mitigating Cognitive Side Effects Associated with Topiramate
Antai-Otong, D. (2005) · Perspectives In Psychiatric Care · doi:10.1111/j.1744-6163.2005.00018.x · Cited by 3
Fowler, J. C., Oldham, J. M., Hopwood, C. J., & Thomas, K. M. (2018) · Wiley eBooks · doi:10.1002/9781394258970.ch21 · Cited by 4
Calvo, N., Morillas, J., Clougher, D., Rosa, A. R., Bernardo, M., Ramos‐Quiroga, J. A., Amoretti, S., & Ferrer, M. (2025) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2025.04.002 · Cited by 5
“…who suffer from it, causing significant distress and impairment in social, occupational and other important areas of functioning, persisting throughout life and entailing a high economic cost for health systems (American Psychiatric Association, 2022; Dhar et al., 2023; Zanarini et al., 2004).”
Belli, H., Ural, C., & Akbudak, M. (2012) · Dusunen Adam The Journal of Psychiatry and Neurological Sciences · doi:10.5350/dajpn2013260108 · Cited by 3
“Bununla birlikte, kısmi remisyona dahi girmeyen vakalar da görülebilir (39,40).”
Tschöke, S., Uhlmann, C., & Steinert, T. (2010) · Nervenheilkunde · doi:10.1055/s-0038-1628810 · Cited by 2
“Ungünstig hinsichtlich der Wahrscheinlichkeit einer Remission wirkten sich Substanzmissbrauch, sexueller Missbrauch, schlechte berufliche Integration und ängstlich-abhängige Persönlichkeitszüge aus (28, 29, 30).”
BackgroundRecent Developments in the Pharmacologic Management of Personality Disorders
Links, P. S., Boursiquot, P., & Links, M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108333931.087 · Cited by 2
Schulkens, J. E. M., van Alphen, S. P. J., Verhey, F. R. J., & Sobczak, S. (2024) · European Journal of Mental Health · doi:10.5708/ejmh.19.2024.0016 · Cited by 2
“In younger adults with PDs (six years after psychiatric admission), 10% of all patients use five or more medications daily (Zanarini et al., 2004).”
BackgroundResultWöckel, L., Goth, K., Zepf, F. D., Matic, N., Holtmann, M. H., Herpertz‐Dahlmann, B., & Poustka, F. (2010) · Praxis der Kinderpsychologie und Kinderpsychiatrie · doi:10.13109/prkk.2010.59.4.282 · Cited by 3
“Trotzdem wurde bisher lediglich in einer kontrollierten Studie die Kombinationsbehandlung von Olanzapin und Fluoxetin mit der jeweiligen Monotherapie verglichen (Zanarini et al., 2004b).”
BackgroundEvaluating Three Treatments for Borderline Personality Disorder: A Multiwave Study
Clarkin, J. F., Levy, K. N., Lenzenweger, M. F., & Kernberg, O. F. (2013) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.11.2.269 · Cited by 2
Marin, L. K., Kapil-Pair, K. N., Harris, R. E., & Goodman, M. S. (2018) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-017-0124-y · Cited by 2
Ausgewählte Konzepte zur Ätiologie, Pathogenese und Therapie der Borderline-Persönlichkeitsstörung
Riffer, F. (2019) · Psychosomatik im Zentrum · doi:10.1007/978-3-662-58639-6_3 · Cited by 2
Serrano, A., Teissier, E., Franchitto, L. G., Revet, A., Raynaud, J., & Cailhol, L. (2022) · Santé mentale au Québec · doi:10.7202/1098903ar · Cited by 3
Nurnberg, H. G. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11com06844 · Cited by 2
“This study consisted of 3 periods: (1) 2- to 14-day screen-”
MethodMustata, G. T., & Gregory, R. J. (2009) · Medical psychiatry · doi:10.3109/9781420084887.017 · Cited by 2
Borderline Personality Disorder
Emanuele, J. M., & Muehlenkamp, J. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-33228-4_83 · Cited by 2
Damiano, R. F., & Soares, J. C. (2022) · Brazilian Journal of Psychiatry · doi:10.47626/1516-4446-2022-2574 · Cited by 3
Saiz, A. D. C. G., & Bueno, A. C. (2021) · MLS Psychology Research · doi:10.33000/mlspr.v4i2.704 · Cited by 8
Salve, F. D., Rossi, C., Oasi, O., Malvini, L., Meliante, M., Percudani, M., & Messina, I. (2026) · Research in Psychotherapy Psychopathology Process and Outcome · doi:10.4081/ripppo.2026.893 · Cited by 1
“…behaviors, and complex patterns of comorbidity (Ansell et al. , 2007; Broadbear et al ., 2022; Ellison et al. , 2018; Grecucci et al. , 2022; Grecucci et al. , 2023; Leichsenring et al ., 2024; Shaikh et al ., 2017; Swan et al. , 2025; Tate et al ., 2022; Yi et al. , 2025; Zanarini et al ., 2004).”
Risperidone long-acting injection, a promising treatment for patients with bipolar disorder
Dratcu, L., Bamelis, D., & Libretto, S. E. (2005) · Journal of Mental Health · doi:10.1080/09638230500271436 · Cited by 1
Turri, M. G., & Andreatta, L. (2014) · Psychoanalytic Psychotherapy · doi:10.1080/02668734.2014.882390 · Cited by 3
2 Die Borderline-Persönlichkeitsstörung
(2016) · Vandenhoeck & Ruprecht eBooks · doi:10.13109/9783666405693.23 · Cited by 1
Koch, M., Vyssoki, B., Wippel, A., Gmeiner, A., Pruckner, N., & Oberndorfer, R. (2019) · Neuropsychiatrie · doi:10.1007/s40211-019-0308-3 · Cited by 2
Personality Disorders in the Emergency Department
Curry, A., & Riddle, M. C. (2021) · Springer eBooks · doi:10.1007/978-3-030-52520-0_13 · Cited by 2
The Spectrum of Personality Disorders
South, S. C., Oltmanns, T. F., & Krueger, R. F. (2014) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780199328710.013.038 · Cited by 1
Zanarini, M. C., Hein, K. E., Temes, C. M., Frankenburg, F. R., & Fitzmaurice, G. M. (2023) · Journal of Personality Disorders · doi:10.1521/pedi.2023.37.4.456 · Cited by 1
Self-citationBitran, A., Temes, C. M., Gecha, T. C., Glass, I. V., Frankenburg, F. R., Fitzmaurice, G. M., & Zanarini, M. C. (2023) · Journal of Personality Disorders · doi:10.1521/pedi.2023.37.6.678 · Cited by 1
Self-citationBorderline Personality Disorder in Individuals with Intellectual Disability
Cowan, A. (2018) · Journal of Childhood & Developmental Disorders · doi:10.4172/2472-1786.100069 · Cited by 1
Majdara, E., Boogar, I. R., Talepasand, S., & Gregory, R. J. (2019) · Journal of Neurodevelopmental Cognition · doi:10.29252/jncog.1.1.1 · Cited by 1
“This disorder is associated with a high utilization rate of medical and psychiatric services (2) and has a significant comorbidity with other mental disorders (2).”
BackgroundFigueroa, R. A., León, T., & Sorensen, R. (2016) · Summa Psicológica · doi:10.18774/448x.2016.13.304 · Cited by 1
Trastorno límite de la personalidad: actualización clínico-fenomenológica y terapéutica
Lugo, G. F. O., & Molina, F. J. M. (2021) · Revista de Psicología Universidad de Antioquia · doi:10.17533/udea.rp.e342752 · Cited by 3
Guillén, V., Miñana, S. B., Fonseca-Baeza, S., Pérez, S., García‐Alandete, J., Marco, H., & Botella, C. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.1097959 · Cited by 5
BATEMAN, A. W., & Zanarini, M. C. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544392.045 · Cited by 2
Self-citationPsychiatry: personality disorders
Tyrer, P. J. (2004) · Medicine · doi:10.1383/medc.2004.32.7.1 · Cited by 1
Embodied Expertise: The Science and Affect of Psychotherapy.
Crăciun, M. (2013) · Deep Blue (University of Michigan) · Cited by 1
Telehealth Partial Hospital Level of Care and Borderline Personality Disorder
Zimmerman, M., Terrill, D. R., Ward, M., D’Avanzato, C., & Wilner, J. G. (2021) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.21lr14037a · Cited by 1
(2011) · Wiley eBooks · doi:10.1002/9781118099254.refs · Cited by 1
Pabst, A. (2013) · KOPS (University of Konstanz)
Economic aspects of treatment for borderline personality disorder. Theory versus practice
van Asselt, A. D. I. (2008) · Research Publications (Maastricht University) · doi:10.26481/dis.20081031aa
Navas, A. F. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Persönlichkeitsstörungen im Spannungsfeld zwischen Biologie und Sozialisation (ICD-10 F6)
Fiedler, P. A., & Herpertz, S. C. (2012) · Elsevier eBooks · doi:10.1016/b978-3-437-24903-7.10019-8
Role of mood stabilizers in borderline personality disorder (BPD)
Links, P. S. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0007-9
Guideline Development Group Membership
Tyrer, P. J., Kendall, T., BATEMAN, A. W., Psychiatrist, C., Bayliss, L., & Bouras, N. (2005)
Diamond, D. (2012) · Psychoanalytic Psychology · doi:10.1037/a0030405
Thorsrud, T. (2014) · NORA - Norwegian Open Research Archives
Persönlichkeitsstörungen im Spannungsfeld zwischen Biologie und Sozialisation (ICD-10 F6)
Fiedler, P. A., & Herpertz, S. C. (2009) · Elsevier eBooks · doi:10.1016/b978-3-437-24900-6.50021-6
Transference-Focused Psychotherapy (TFP) Principles in the Pharmacotherapy of Personality Disorders
Hersh, R. G., Caligor, E., & Yeomans, F. E. (2016) · Springer eBooks · doi:10.1007/978-3-319-44091-0_6
Sexual minority stress and psychological risk for nonsuicidal self-injury
Fehling, K. B. (2016) · doi:10.7282/t3ft8pb6
Borkum, D. B., Frankenburg, F. R., Fitzmaurice, G. M., Athanasiadi, A., Temes, C. M., Reich, D. B., & Zanarini, M. C. (2018) · Journal of Personality Disorders · doi:10.1521/pedi_2018_32_335
Self-citationApego y rasgos límites de la personalidad: el papel mediador de la regulación emocional
Casado, M. V. (2018) · Gredos (University of Salamanca) · doi:10.14201/gredos.137558
Psychiatric Comorbidities and Appropriate Psychopharmacology
Jenkins, J. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-90743-7_11
Links, P. S., Links, M., & Boursiquot, P. (2019) · Elsevier eBooks · doi:10.1016/b978-2-294-76266-6.00004-5
Lewis, J. (2020) · Scholars' Bank (University of Oregon)
Persönlichkeitsstörungen im Spannungsfeld zwischen Biologie und Sozialisation (ICD-10 F6)
Fiedler, P. A., & Herpertz, S. C. (2006) · Elsevier eBooks · doi:10.1016/b978-343724130-7.50016-x
Current awareness in human psychopharmacology
(2004) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.632
Letter: Prescribing and borderline personality disorder
Criddle, D., Wood, C., Chanen, A. M., & Thompson, K. N. (2016) · Australian Prescriber · doi:10.18773/austprescr.2016.064
Harwood, T. M., & L’Abate, L. (2009) · Springer eBooks · doi:10.1007/978-1-4419-1099-8_11
Borderline-Persönlichkeitsstörung
Schaich, A., Erkens, N., Schweiger, U., & Faßbinder, E. (2018) · PSYCH up2date · doi:10.1055/s-0043-110841
Guillén, V., Miñana, S. B., Fonseca-Baeza, S., Pérez, S., García‐Alandete, J., Marco, H., & Botella, C. (2022) · Research Square · doi:10.21203/rs.3.rs-2067853/v1
Majdara, E., Boogar, I. R., Talepasand, S., & Gregory, R. J. (2022) · Journal of Neurodevelopmental Cognition · doi:10.52547/jncog.2022.103421
Jeung-Maarse, H. (2023) · Research Publications (Maastricht University) · doi:10.26481/dis.20230918hj · Cited by 2
Plante, D. T., Glass, I. V., & Zanarini, M. C. (2025) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.11786 · Cited by 1
“35 This semistructured interview, first introduced to the study at the 6-year follow-up and readminis-tered every 2 years until the conclusion of the study, assesses participant health, lifestyle issues related to physical health (eg, smoking, alcohol consumption), and health care utilization.”
Self-citationJuul, S., McMain, S., Olsen, M. H., Chapman, A. L., Ribeiro, J. P., Storebø, O. J., Kuo, J. R., Hestbæk, E., Kamp, C. B., Rishede, M., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-096436
Psychometric Properties of the Turkish Five-Factor Borderline Inventory-Short Form
Ayan, Ö. E., & İnözü, M. (2025) · Journal of Psychopathology and Behavioral Assessment · doi:10.1007/s10862-025-10261-5 · Cited by 1
Is guardianship a successful intervention for people diagnosed with borderline personality disorder
Withers, M. (2011) · Victoria University Research Repository (Victoria University)
Traynor, J. M., Hudson, C. C., Ren, B., Beard, C., Björgvinsson, Þ., Forgeard, M. J. C., & Hsu, K. J. (2026) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2026.152732
Borderline personality disorder, day hospitals, and mentalization
BATEMAN, A. W., & Fonagy, P. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544439.009
Metadata
- Authors
- Zanarini, M. C., Frankenburg, F. R., Hennen, J., & Silk, K. R.
- Affiliations
- Harvard University (US)
- ORCID
- Zanarini, Mary C.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2004-01-15
- Volume
- 65
- Issue
- 1
- Pages
- 28-36
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2993584274
- Cited by
- 285
- References
- 0
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 7 · 2023: 6 · 2022: 11 · 2021: 14 · 2020: 11 · 2019: 18 · 2018: 21 · 2017: 9 · 2016: 16 · 2015: 10 · 2014: 16 · 2013: 12 · 2012: 17
- FWCI
- 18.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (MH-62169, R29MH047588, R01MH062169, MH-47588)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Social Sciences › Psychology › Clinical Psychology › Psychiatric care and mental health services
- Keywords
- borderline personality disorder, mental health service utilization, psychiatric hospitalization, outpatient psychotherapy, polypharmacy, psychotropic drugs, Axis II personality disorders, long-term follow-up, treatment continuity
- MeSH terms
- Adolescent, Adult, Borderline Personality Disorder, Drug Therapy, Female, Hospitalization, Humans, Inpatients, Male, Mental Health Services, Outpatients, Prospective Studies, Psychotherapy, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.